![Leon E. Chen](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Leon E. Chen
Direktor/Vorstandsmitglied bei
EIKON THERAPEUTICS, INC.
Profil
Dr. Leon E.
Chen is a Partner at The Column Group LLC.
He is on the Board of Directors at Eikon Therapeutics, Inc. and Remix Therapeutics, Inc. Dr. Chen was previously employed as an Independent Director by Nurix Therapeutics, Inc., an Independent Director by LogicBio Therapeutics, Inc., a Venture Partner by OrbiMed Advisors Private Equity, a Partner by Skyline Management LLC, a Principal by Venrock Associates, a Founder by KAI Pharmaceuticals, Inc., a Chief Executive & Financial Officer by E-Scape Bio, Inc., and a Board Director by Velia, Inc. He also served on the board at Crescendo Bioscience LLC, Genocea Biosciences, Inc., Pionyr Immunotherapeutics, Inc. and Sutro Biopharma, Inc. He received his undergraduate degree from the University of California, Berkeley, an MBA from Stanford Graduate School of Business and a doctorate degree from Stanford University.
Aktive Positionen von Leon E. Chen
| Unternehmen | Position | Beginn |
|---|---|---|
| EIKON THERAPEUTICS, INC. | Direktor/Vorstandsmitglied | 01.01.2019 |
Remix Therapeutics, Inc.
 Remix Therapeutics, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biotechnology company develops molecule therapies to modulate RNA processing and address the underlying drivers of diseases | Direktor/Vorstandsmitglied | - |
The Column Group LLC
 The Column Group LLC Investment ManagersFinance TCG invests in companies located in the United States. The firm focuses on drug discovery, biology, chemistry, and technology sectors. It provides financing for early and later stage capital requirements with an investment size of USD 50 - 60 million. | Private Equity Investor | 01.10.2019 |
Ehemalige bekannte Positionen von Leon E. Chen
| Unternehmen | Position | Ende |
|---|---|---|
| LOGICBIO THERAPEUTICS, INC. | Direktor/Vorstandsmitglied | 16.11.2022 |
| NURIX THERAPEUTICS, INC. | Direktor/Vorstandsmitglied | 28.05.2021 |
OrbiMed Advisors Private Equity
 OrbiMed Advisors Private Equity Investment ManagersFinance OrbiMed Advisors Private Equity invests in companies located across the globe primarily in North America, Asia, Europe and Israel. The firm focuses on biopharmaceuticals, medical technology and healthcare services. It participates in seed-stage, early stage, growth transactions. It also provides debt capital and monetize royalty streams and invests in publicly-traded companies. | Private Equity Investor | 30.09.2019 |
ESCAPE Bio, Inc.
 ESCAPE Bio, Inc. BiotechnologyHealth Technology Develops small molecule therapeutics against genetic targets for neurodegenerative disease | Vorstandsvorsitzender | 23.08.2018 |
Skyline Management LLC
 Skyline Management LLC Investment ManagersFinance Skyline Management invests in companies located in the United States. The firm focuses on companies operating in the fields of healthcare market, including biotechnology, therapeutics, medical devices, consumables and equipment for life sciences research and healthcare information technology. It participates in financing for early stage and later stage transactions with an investment size between USD 15 and 25 million. | Private Equity Investor | 30.06.2013 |
Ausbildung von Leon E. Chen
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
94
Beziehungen ersten Grades
18
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 18 |
|---|---|
Venrock Associates
 Venrock Associates Investment ManagersFinance Venrock Associates invests in companies located in the US. The firm focuses on sectors such as intelligent enterprise & AI, security & infrastructure, fintech, healthcare IT, defense & Aerospace, robotics & autonomy and consumer sectors. It participates in early and later stage transactions. | Finance |
KAI Pharmaceuticals, Inc.
 KAI Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Discovers and develops biopharmaceutical drugs | Health Technology |
Crescendo Bioscience LLC
 Crescendo Bioscience LLC Miscellaneous Commercial ServicesCommercial Services Develops and commercializes quantitative blood tests for rheumatoid arthritis and other autoimmune diseases | Commercial Services |
Sutro Biopharma, Inc.
 Sutro Biopharma, Inc. Pharmaceuticals: MajorHealth Technology Develops new products in protein vaccines and therapeutics | Health Technology |
Genocea Biosciences, Inc.
 Genocea Biosciences, Inc. BiotechnologyHealth Technology Operates as clinical stage biotechnology company that discovers and develops novel cancer immunotherapies | Health Technology |
Nurix Therapeutics, Inc.
 Nurix Therapeutics, Inc. BiotechnologyHealth Technology Operates as a a clinical stage biopharmaceutical company that discovers, develops and commercializes oral, small molecule therapies for the treatment of cancer & immune disorders | Health Technology |
Stanford University
 Stanford University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Skyline Management LLC
Skyline Management LLC Investment ManagersFinance Skyline Management invests in companies located in the United States. The firm focuses on companies operating in the fields of healthcare market, including biotechnology, therapeutics, medical devices, consumables and equipment for life sciences research and healthcare information technology. It participates in financing for early stage and later stage transactions with an investment size between USD 15 and 25 million. | Finance |
University of California, Berkeley
 University of California, Berkeley Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
OrbiMed Advisors Private Equity
OrbiMed Advisors Private Equity Investment ManagersFinance OrbiMed Advisors Private Equity invests in companies located across the globe primarily in North America, Asia, Europe and Israel. The firm focuses on biopharmaceuticals, medical technology and healthcare services. It participates in seed-stage, early stage, growth transactions. It also provides debt capital and monetize royalty streams and invests in publicly-traded companies. | Finance |
The Column Group LLC
The Column Group LLC Investment ManagersFinance TCG invests in companies located in the United States. The firm focuses on drug discovery, biology, chemistry, and technology sectors. It provides financing for early and later stage capital requirements with an investment size of USD 50 - 60 million. | Finance |
Stanford Graduate School of Business
 Stanford Graduate School of Business Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
LogicBio Therapeutics, Inc.
 LogicBio Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes medicines and therapies for bone metabolism, cardiology, neurology and rare diseases | Health Technology |
Pionyr Immunotherapeutics, Inc.
 Pionyr Immunotherapeutics, Inc. BiotechnologyHealth Technology Develops antibody-based Immuno-oncology therapeutics | Health Technology |
ESCAPE Bio, Inc.
ESCAPE Bio, Inc. BiotechnologyHealth Technology Develops small molecule therapeutics against genetic targets for neurodegenerative disease | Health Technology |
Eikon Therapeutics, Inc.
 Eikon Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical biopharmaceutical and drug discovery company | Health Technology |
Remix Therapeutics, Inc.
Remix Therapeutics, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biotechnology company develops molecule therapies to modulate RNA processing and address the underlying drivers of diseases | Health Technology |
Velia, Inc.
 Velia, Inc. Packaged SoftwareTechnology Services Provides software development services | Technology Services |
